AI Analysis
AI-generated analysis. Always verify with the original filing.
Net loss expanded dramatically to -$233.1M from -$12.7M, reflecting a -1740.6% YoY change driven by non-cash fair value declines in the new ATH digital asset treasury strategy amid the pivot to GPU compute services, with operating losses expected to persist during scaling.
Key Takeaways
1Net loss widened to -$233.1M from -$12.7M, a -1740.6% YoY change, as the Company launched its ATH treasury strategy exposing it to digital asset volatility.
2Capital expenditures dropped to $0 from $9.5K, supporting an asset-light model focused on distributed GPU compute via the Aethir network.
3Revenue increased from the prior year primarily due to completion of a tumor-specific 3D model in the legacy drug discovery business.
4Operating expenses decreased in 2025 due to elimination of 2024 staff-related sales/marketing costs and severance expenses.
5Cash used in operating activities decreased primarily from lower cash operating losses and reduced cash used in working capital, including higher accounts payable and accrued expenses.
6Management expects operating losses to continue near-term while scaling compute services and ATH treasury strategy, with alternative liquidity sources available.